Intelligence Platform
Patents
Browse 183 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 11142750
Optimized engineered meganucleases having specificity for a recognition sequence in the He
granted patentUS 11129791
Drug delivery device
granted patentUS 11096996
Cancer vaccines and vaccination methods
granted patentUS 11078245
Colon and pancreas cancer peptidomimetics
granted patentUS 11053484
Genetically-modified T cells comprising a modified intron in the T cell receptor alpha gen
granted patentUS 11021576
Polymeric stabilizing formulations
granted patentUS 11014931
3-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazol
granted patentUS 11008548
Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)
granted patentUS 11001641
Monoclonal antibody therapy for pancreas cancer
granted patentUS 10973862
Bifidobacterium longum for treating obesity and associated metabolic disorders
granted patentUS 10927141
Salts and crystal forms of GABAA positive allosteric modulator
granted patentUS 10851358
Engineered meganucleases specific for recognition sequences in the hepatitis B virus genom
granted patentUS 10813366
Bifidobacterium longum NCIMB 41676
granted patentUS 10800833
Co-stimulatory domains for use in genetically-modified cells
granted patentUS 10799535
Engineered meganucleases with recognition sequences found in the human T cell receptor alp
granted patentUS 10792481
Implantable drug delivery device
granted patentUS 10758595
Treatment of retinitis pigmentosa using engineered meganucleases
granted patentUS 10745665
Nucleic acid molecules encoding an engineered antigen receptor and an inhibitory nucleic a
granted patentUS 10688056
Implantable medical devices for extended release of therapeutic agents
granted patentUS 10689443
Humanized monoclonal antibodies and methods of use for the diagnosis and treatment of colo
granted patentUS 10689719
Bifidobacterium longum
granted patentUS 10662416
Engineered meganucleases specific for recognition sequences in the hepatitis B virus genom
granted patentUS 10662440
Self-limiting viral vectors encoding nucleases
granted patentUS 10653169
Food thickening agent, method for producing food thickening agent
granted